Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Active, Not Recruiting

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

NCT03808662

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +19 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments

NCT04454437

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Triple-negative Breast Cancer, +5 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Liaoning Cancer Hospital & Institute Shenyang, Liaoning, China
  • Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine Hangzhou, Zhejiang, China
  • Chinese PLA General Hospital Beijing, China
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +33 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Dresden, Saxony, Germany
View Trial Details
Active, Not Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • Ucsf /Id# 257705 San Francisco, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT05544929

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
Locations
  • Massachusetts General Hospital . Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Ribociclib and Bicalutamide in AR+ TNBC

NCT03090165

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Michigan State University Lansing, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Rochester Medical Center Rochester, New York, United States
View Trial Details

Related conditions